Search Scholars Central
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
Advanced searchHide advanced search
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Conference abstract · 2018 Conference abstract · 1 Dec 2018 COPD Conference 2018: The role of double bronchodilation in COPD treatment- Marousa Kouvela- University of Athens, Greece
Bronchodilators assume a focal job in COPD treatment. Toward the finish of the earlier year, the GOLD (Global Initiative for Chronic Obstructive Lung Disease) system for the determination, the board ... COPD gatherings…
Research article · 2015 COPD Treatment Preference Study: A Conjoint Analysis of Preferred Drug Treatments
symptoms was long acting-bronchodilatator. Conclusion: The major expectation and choice of COPD patients from their drug treatment were that the number of days without complaints was to be maximum ... long acting…
Editorial · 2020 The role of double bronchodilation in COPD treatment
Bronchodilators play a central role in COPD treatment. At the end of the previous year, the GOLD (Global Initiative for Chronic Obstructive Lung Disease) strategy for the diagnosis, management ... option to all COPD…
Mini review · 28 Jul 2023 Comprehensive Overview of COPD Treatment
healthcare systems due to its high prevalence, morbidity and mortality. However, advances in COPD treatment have provided patients with a range of therapeutic options aimed at improving their quality ... life and…
Conference abstract · 11 Jul 2016 Therapeutic potential for COPD treatment, evidence for stem cell and natural product therapy
studies various possible therapeutic potential of natural product and stem cell for treatment of COPD were examined. The effect of adipose derived stromal cells (ASCs) on tracheal responsiveness, interleukin…
Conference abstract · 31 Jan 2022 Ventilation/Perfusion Mismatch: A Novel Target for COPD Treatment
intolerance. Although much attention has been paid to pharmacological treatment of mechanical abnormalities (e.g., bronchodilators to deflate the lungs) in COPD, increasing neurochemical afferent activity, secondary to…
Review article · 7 Jul 2022 An Overview of COPD Treatment
inhaled steroids, andother treatments can help manage symptoms and limit future harm. The most common chronic cause of diseaseand mortality in the world is COPD. Very few researches have examined
Conference abstract · 22 Oct 2018 Quality of life as an assessment of COPD treatment
Chronic Obstructive Pulmonary Disease (COPD) is an important health problem worldwide and
Commentary · 27 Sep 2024 Pharmacological Approaches to Asthma and COPD Treatment
Rapid communication · 25 Mar 2024 Innovative Approaches to COPD Treatment: Current and Future Perspectives
Short communication · 2021 The role of double bronchodilation in COPD treatment- Marousa Kouvela- University of Athens
Conference abstract · 14 Jul 2016 Treatment of COPD with oriental medicine
Eastern Medicine to be fully integrated with a new paradigm for the treatment of the COPD patient. With the shift from “Fee for Service” to “Pay for Performance”, there ... using prevention & wellness to help maintain…
Case report · 29 Feb 2024 Personalized Medicine in COPD: Tailoring Treatment for Better Outcomes
Personalized Medicine in Chronic Obstructive Pulmonary Disease (COPD): Tailoring Treatment for Better Outcomes Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disorder characterized by airflow…
Review article · 28 Nov 2017 Individualized Care in COPD: Updated Guidelines from Revised GOLD 2017 Report
Chronic obstructive lung disease (COPD) is a major cause of morbidity and
Conference abstract · 31 Jan 2022 Current insights on clinical efficacy of roflumilast for treatment of COPD, asthma and ACOS
Phosphodiesterase-4 inhibitors (PDE4) are of great interest for the treatment of airway inflammatory diseases due to its broad anti-inflammatory effects. Roflumilast is a selective PDE4 inhibitor that inhibits…
Conference abstract · 8 Oct 2015 Treatment of COPD with Umeclidinium bromide-Vilanterol combination
Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable, and treatable disease characterized by airflow limitation that is not fully reversible and is usually progressive during follow ... bronchodilator…
Other · 23 Jul 2016 A twice-daily, fixed-dose combination of aclidinium bromide and formoterol fumarate for the treatment of COPD
Inhaled long-acting β2-agonists or long-acting muscarinic antagonists monotherapies are
Conference abstract · 29 May 2017 Novel pharmacological strategies for the treatment of COPD and its comorbidities
Statement of the Problem: Reactive oxygen species (ROS) are a family of
Conference abstract · 14 Sep 2018 Trying to quit smoking questionnaire: A new instrument for predicting smoking cessation in patients with chronic obstructive pulmonary disease
they continue to smoke aft er diagnosis. Quitting is therefore crucial to COPD treatment, but many patients find it difficult to stop smoking. To investigate which factors infl uence quit
Opinion · 29 Jun 2024 Preventing Chronic Obstructive Pulmonary Disease (COPD): Effective Strategies and Treatment Options
progressive airflow limitation and respiratory symptoms. This abstract explores effective strategies and treatment options aimed at preventing COPD onset and managing its progression. Key preventive measures include…
Research article · 1 Sep 2020 A comparison of effectiveness of Dual and Triple dose therapy in COPD
Chronic obstructive pulmonary disease (COPD) has turned out to be the third
Article · 3 Nov 2025 Microbiome Cross-Talk in COPD: Insights into the Gut?Lung Axis and Emerging Treatments
interactions in COPD, explores the molecular mechanisms underlying gut-lung interactions, and highlights new microbiome-based strategies that have the potential to transform disease prevention and treatment
Mini review · 30 Nov 2023 Chronic Obstructive Pulmonary Disease (COPD): Origins, Indications, Detection, and Treatment
Chronic Obstructive Pulmonary Disease (COPD) is a widespread and progressive lung disorder

